drug

(redirected from Investigational drug)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial.

drug

1. any synthetic, semisynthetic, or natural chemical substance used in the treatment, prevention, or diagnosis of disease, or for other medical reasons
2. a chemical substance, esp a narcotic, taken for the pleasant effects it produces
3. drug on the market a commodity available in excess of the demands of the market

drug

[drəg]
(pharmacology)
Any substance used internally or externally as a medicine for the treatment, cure, or prevention of a disease.
A narcotic preparation.

Drug

principle of evil. [Zoroastrianism: Leach, 325]
See: Evil

Drugs

(dreams)
The interpretation of drugs in your dreams depends on the relationship you have with drugs in your daily life and whether they are doctor prescribed or not. If you are a drug user, then the drugs are an extension of what you normally do, and you need to look at the other details of your dream to get a good interpretation. However, if you use drugs rarely or never, then this dream could represent a need to get well, to escape from daily stress, and a desire to get quick relief. The drugs could be suggesting a need for healing and getting in balance. Your unconscious mind may be suggesting outrageous things in hopes that you get the message to “have fun, dream dreams, and get out of your own head!” Please keep in mind that the purpose of dreams is to raise our consciousness and to assist us in having better lives. The message in the dream about drug use is most likely not encouraging you to use drugs but it may represent a need to feel better or get better.
References in periodicals archive ?
Act 345 of 2014), a clear identification of the specific proposed investigational drug is required in the informed consent document.
The new rule "Expanded Access to Investigational Drugs for Treatment Use" makes investigational drugs more widely available to patients by spelling out procedures and standards.
Moreover, anecdotal evidence associated with an adverse reaction to an investigational drug in an uncontrolled setting might raise safety concerns that could hinder market approval or create adverse publicity.
Thirdly, the FDA believes that many of the issues presented by investigational drugs in Phase 1 trials are different to larger Phase 2 or 3 trials.
Surrogate markers: Laboratory tests, usually CD4 T cell count and viral load, that are used to estimate the health benefit of an investigational drug.
Understandably, if an investigational drug helps you, you may wish to continue to take it after the trial has been completed.
The FDA would permit widespread treatment IND use of an investigational drug if the drug is being investigated in a controlled clinical trial under an IND designed to support a marketing application for the expanded access use (or such clinical trial or trials have been completed), the sponsor is actively pursuing marketing approval for the expanded access use with due diligence, and there is sufficient evidence of safety and effectiveness to support the expanded access.
RP103 is Raptor's investigational drug candidate for the potential treatment of nephropathic cystinosis.

Full browser ?